James E. Kirby
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Legionella and Acanthamoeba research
- Vibrio bacteria research studies
Papers in
-
- SARS-CoV-2 detection and testing 11
- Antimicrobial Resistance in Staphylococcus 8
-
- Antibiotic Resistance in Bacteria 30
- Co-authors
- Thea Brennan-Krohn (15 shared papers)Scott Duong (5 shared papers)Ralph R. Isberg (3 shared papers)Jeannie T. Lee (4 shared papers)Rudolph E. Tanzi (1 shared paper)Martin Ingelsson (1 shared paper)Stephanie J. Soscia (1 shared paper)Kevin J. Washicosky (1 shared paper)
- Journals
- Journal of Clinical Microbiology (17 papers)Diagnostic Microbiology and Infectious Disease (9 papers)Antimicrobial Agents and Chemotherapy (8 papers)Infection and Immunity (5 papers)Journal of Visualized Experiments (4 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
James E. Kirby
107 papers receiving 4.1k citations
James E. Kirby's Hit Papers
Peers
Comparison fields: 5 of 162
- Molecular Medicine 481
- Endocrinology 452
- Biological Psychiatry 170
- Applied Microbiology and Biotechnology 83
- Clinical Biochemistry 297
Countries citing papers authored by James E. Kirby
This map shows the geographic impact of James E. Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Kirby more than expected).
Fields of papers citing papers by James E. Kirby
This network shows the impact of papers produced by James E. Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Kirby. The network helps show where James E. Kirby may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Kirby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide Hit paper breakdown → | 2010 | 856 |
| 2 | 2013 | 401 | |
| 3 | 1998 | 201 | |
| 4 | 2003 | 148 | |
| 5 | 2001 | 136 | |
| 6 | 2012 | 135 | |
| 7 | 2017 | 117 | |
| 8 | 2001 | 115 | |
| 9 | 2020 | 106 | |
| 10 | 2002 | 88 | |
| 11 | 2020 | 87 | |
| 12 | 2018 | 87 | |
| 13 | 2018 | 85 | |
| 14 | 2020 | 74 | |
| 15 | 2016 | 61 | |
| 16 | 2020 | 60 | |
| 17 | 2017 | 57 | |
| 18 | 2015 | 52 | |
| 19 | 2014 | 47 | |
| 20 | 2017 | 46 |
About James E. Kirby
James E. Kirby is a scholar working on Infectious Diseases, Molecular Medicine, Molecular Biology, Epidemiology and Clinical Biochemistry, having authored 118 papers that have together received 4.3k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (30 papers), Bacterial Identification and Susceptibility Testing (19 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), SARS-CoV-2 detection and testing (11 papers), Legionella and Acanthamoeba research (10 papers), Pharmaceutical and Antibiotic Environmental Impacts (10 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Streptococcal Infections and Treatments (5 papers). The work is most often cited by research in Molecular Medicine (481 citations), Endocrinology (452 citations), Biological Psychiatry (170 citations), Applied Microbiology and Biotechnology (83 citations) and Clinical Biochemistry (297 citations). James E. Kirby has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Thea Brennan-Krohn, Scott Duong, Ralph R. Isberg, Jeannie T. Lee, Rudolph E. Tanzi, Martin Ingelsson, Stephanie J. Soscia, Kevin J. Washicosky, Bradley T. Hyman and Mark A. Burton. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy, Infection and Immunity and Journal of Visualized Experiments.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.